Your browser doesn't support javascript.
loading
Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.
Kim, Juhyeun; Tabner, Andrew John; Johnson, Graham David; Brumback, Babette A; Hartzema, Abraham.
Afiliação
  • Kim J; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, P.O. Box 100496, Gainesville, FL, USA. jhkim.ek@gmail.com.
  • Tabner AJ; REMEDY, Emergency Department, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK.
  • Johnson GD; REMEDY, Emergency Department, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK.
  • Brumback BA; Department of Biostatistics, College of Public Health and Health Professions, College of Medicine, University of Florida, P.O. Box 117450, Gainesville, FL, 32611, USA.
  • Hartzema A; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, P.O. Box 100496, Gainesville, FL, USA.
Dig Dis Sci ; 65(1): 292-300, 2020 01.
Article em En | MEDLINE | ID: mdl-31468265
ABSTRACT

BACKGROUND:

Codeine has a spasmodic effect on sphincter of Oddi and is suspected to cause acute pancreatitis in patients with a history of cholecystectomy.

AIMS:

To assess the association between codeine use and acute pancreatitis in patients with a previous cholecystectomy.

METHODS:

We conducted a retrospective nested case-control study using the 2005-2015 MarketScan® Commercial Claims and Encounters Database. The cohort included patients aged 18-64; cohort entry began 365 days after cholecystectomy. Odds ratios (ORs) and 95% CIs for acute pancreatitis hospitalization were estimated comparing use of codeine with non-use of codeine. In a secondary analysis, use of codeine was compared with an active comparator use of non-steroidal anti-inflammatory drugs (NSAIDs).

RESULTS:

Of the 664,083 patients included in the cohort, 1707 patients were hospitalized for acute pancreatitis (incidence 1.1 per 1000 person-years) and were matched to 17,063 controls. Compared with non-use of codeine, use of codeine was associated with an increased risk of acute pancreatitis (OR 2.67; 95% CI 1.63, 4.36), particularly elevated in the first 15 days of codeine use (OR 5.37; 95% CI 2.70, 10.68). Compared with use of NSAIDs, use of codeine was also associated with an increased risk of acute pancreatitis (OR 2.64; 95% CI 1.54, 4.52).

CONCLUSION:

Codeine is associated with an increased risk of acute pancreatitis in patients who have previously undergone cholecystectomy; greater clinician awareness of this association is needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Colecistectomia / Codeína / Analgésicos Opioides Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Dig Dis Sci Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Colecistectomia / Codeína / Analgésicos Opioides Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Dig Dis Sci Ano de publicação: 2020 Tipo de documento: Article